albendazole (Albenza) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PREGNANCY: There are no adequate clinical trials of albendazole administration during pregnancy. Albendazole should only be used during pregnancy if the potential benefit of treatment justifies the potential risk to the fetus. Albendazole has been classified FDA as pregnancy risk category C.

NURSING MOTHERS: It is not known if albendazole is excreted in human milk. Due to the lack of safety data, albendazole should be used cautiously during breastfeeding.

SIDE EFFECTS: Side effects which occurred with a frequency of = 1% include:

Side effects which occurred with a frequency of <1% include:

Other side effects of undefined frequency include:

  • aplastic anemia,
  • bone marrow suppression,
  • decrease in white blood count,
  • acute liver failure,
  • hepatitis, increase in liver enzymes,
  • severe skin rashes such as Steven-Johnson's syndrome, and
  • acute kidney failure.

REFERENCE: FDA Prescribing Information.

Medically Reviewed by a Doctor on 11/21/2014

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index